thiazoles has been researched along with thromboplastin in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernat, A; Corseaux, D; Herbert, JM; Lale, A | 1 |
Higure, A; Itoh, H; Katoh, H; Nagafuchi, Y; Nakamura, S; Ohsato, K; Okamoto, K; Okazaki, K; Takeda, S; Todoroki, H | 1 |
Betz, A; Sinha, U; Wong, PW | 1 |
Ishii, H; Kanehara, H; Miyamori, I; Oida, K; Suzuki, J; Tohda, G | 1 |
Dice, TA; Girard, TJ; Kurumbail, RG; Lachance, RM; Parlow, JJ; South, MS; Stallings, WC; Stegeman, RA; Stevens, AM | 1 |
Case, BL; Clare, M; Dice, TA; Fenton, RL; Girard, TJ; Hayes, MJ; Jones, DE; Kurumbail, RG; Lachance, RM; Neumann, WL; Nicholson, NS; Parlow, JJ; South, MS; Stallings, WC; Stegeman, RA; Stevens, AM; Wood, RS | 1 |
Carlsson, K; Carlsson, U; Hammarström, P; Herland, A; Persson, E; Svensson, M; Wiréhn, J | 1 |
Chuang, YC; Huang, H; Huang, HC; Wang, HJ | 1 |
Fukuda, T; Furugohri, T; Kita, A; Morishima, Y; Shibano, T; Tsuji, N | 1 |
Chen, C; Deng, J; Guo, T; Hu, Y; Jiang, X; Li, L; Mei, H; Pang, Z; Shen, S; Shi, W; Wang, H; Zhang, B | 1 |
Honda, Y; Morishima, Y | 1 |
Furugohri, T; Morishima, Y | 1 |
Honda, Y; Kamisato, C; Morishima, Y | 1 |
13 other study(ies) available for thiazoles and thromboplastin
Article | Year |
---|---|
Hypoxia primes endotoxin-induced tissue factor expression in human monocytes and endothelial cells by a PAF-dependent mechanism.
Topics: Animals; Cells, Cultured; Endotoxins; Humans; Hypoxia; Interleukin-1; Lipopolysaccharides; Monocytes; Platelet Activating Factor; Rabbits; Thiazoles; Thrombophlebitis; Thromboplastin; Umbilical Cord | 1996 |
Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils.
Topics: Animals; Aspartate Aminotransferases; Blood Coagulation; Cholangitis; Disease Models, Animal; Leukocytes; Liver; Male; Neutrophils; Platelet Activating Factor; Rabbits; Thiazoles; Thiazolidines; Thromboplastin | 1998 |
Inhibition of factor Xa by a peptidyl-alpha-ketothiazole involves two steps. Evidence for a stabilizing conformational change.
Topics: Amino Acid Sequence; Catalytic Domain; Enzyme Stability; Factor Xa; Factor Xa Inhibitors; Humans; In Vitro Techniques; Kinetics; Oligopeptides; Protein Conformation; Serine Proteinase Inhibitors; Spectrometry, Fluorescence; Thiazoles; Thromboplastin | 1999 |
Thrombomodulin expression by THP-1 but not by vascular endothelial cells is upregulated by pioglitazone.
Topics: Antibodies, Monoclonal; Blotting, Northern; CD4 Antigens; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Endothelium, Vascular; Flow Cytometry; Gene Expression Regulation; HL-60 Cells; Humans; Lipopolysaccharide Receptors; Pioglitazone; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazoles; Thiazolidinediones; Thrombomodulin; Thromboplastin; Transcription Factors; Tumor Cells, Cultured; Up-Regulation | 2002 |
Polymer-assisted solution-phase library synthesis and crystal structure of alpha-ketothiazoles as tissue factor VIIa inhibitors.
Topics: Amino Acid Sequence; Binding Sites; Combinatorial Chemistry Techniques; Crystallography, X-Ray; Enzyme Inhibitors; Factor VIIa; Humans; Inhibitory Concentration 50; Ketones; Models, Molecular; Polymers; Recombinant Proteins; Structure-Activity Relationship; Thiazoles; Thrombin; Thromboplastin | 2003 |
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Topics: Antithrombin III; Binding Sites; Combinatorial Chemistry Techniques; Crystallography, X-Ray; Drug Design; Factor VIIa; Fibrinolytic Agents; Humans; Inhibitory Concentration 50; Models, Molecular; Pyrazines; Recombinant Proteins; Serine Proteinase Inhibitors; Structure-Activity Relationship; Thiazoles; Thrombin; Thromboplastin | 2003 |
Activity, folding, misfolding, and aggregation in vitro of the naturally occurring human tissue factor mutant R200W.
Topics: Amyloid; Anilino Naphthalenesulfonates; Arginine; Benzothiazoles; Extracellular Space; Factor VIIa; Genetic Carrier Screening; Humans; Kinetics; Mutation; Nephelometry and Turbidimetry; Protein Binding; Protein Denaturation; Protein Folding; Spectrometry, Fluorescence; Substrate Specificity; Thiazoles; Thromboplastin; Tryptophan | 2005 |
Paclitaxel induces up-regulation of tissue factor in human aortic endothelial cells.
Topics: Antineoplastic Agents, Phytogenic; Aorta, Thoracic; Blotting, Western; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug-Eluting Stents; Endothelial Cells; Endothelium, Vascular; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; In Vitro Techniques; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Thrombin; Thromboplastin; Up-Regulation | 2009 |
Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats.
Topics: Animals; Antithrombins; Azetidines; Benzylamines; Blood Coagulation Disorders; Factor Xa Inhibitors; Heparin; Male; Pyridines; Rats; Rats, Wistar; Thiazoles; Thromboplastin | 2012 |
A tissue factor targeted nanomedical system for thrombi-specific drug delivery.
Topics: Animals; Blood Coagulation; Brain; Cell Death; Cells, Cultured; Coumarins; Drug Delivery Systems; Endothelial Cells; Factor VII; Green Fluorescent Proteins; Injections, Intravenous; Nanomedicine; Nanoparticles; Particle Size; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Spectrometry, Fluorescence; Static Electricity; Thiazoles; Thromboplastin; Thrombosis; Tumor Necrosis Factor-alpha | 2012 |
Thrombin generation induced by tissue factor plus ADP in human platelet rich plasma: A potential new measurement to assess the effect of the concomitant use of an oral factor Xa inhibitor edoxaban and P2Y12 receptor antagonists.
Topics: Adenosine; Adenosine Diphosphate; Blood Coagulation; Blood Coagulation Tests; Factor Xa Inhibitors; Humans; Platelet-Rich Plasma; Purinergic P2Y Receptor Antagonists; Pyridines; Thiazoles; Thrombin; Thromboplastin; Ticagrelor | 2015 |
Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin.
Topics: Anticoagulants; Antithrombins; Azetidines; Benzylamines; Blood Coagulation; Dose-Response Relationship, Drug; Drug Synergism; Factor Xa Inhibitors; Heparin; Humans; Pyridines; Thiazoles; Thrombin; Thromboplastin | 2015 |
Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
Topics: Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Factor Xa; Factor Xa Inhibitors; Female; Fondaparinux; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polysaccharides; Pyridines; Thiazoles; Thromboplastin | 2016 |